Worldwide Industry for Allergy Immunotherapies to 2026 - Featuring Stallergenes Greer, HAL Allergy & DBV Technologies Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global allergy immunotherapies market reached a value of US$ 2.3 Billion in 2020. Looking forward, the publisher expects the global allergy immunotherapies market to reach a value of US$ 4.10 Billion by 2026, exhibiting a CAGR of 10.50% during 2021-2026.

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system's response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient's life.

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world.

Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.

Companies Mentioned

• ALK-Abello A/S
• Allergy Therapeutics
• Stallergenes Greer
• HAL Allergy Group
• DBV Technologies
• Merck Group
• Aimmune Therapeutics
• Circassia Pharmaceuticals
• Anergis SA
• Biomay AG

Key Questions Answered in This Report:

• How has the global allergy immunotherapies market performed so far and how will it perform in the coming years?
• What are the key regional markets in the global allergy immunotherapies industry?
• What has been the impact of COVID-19 on the global allergy immunotherapies industry?
• What is the breakup of the market based on the treatment type?
• What is the breakup of the market based on the allergy type?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the global allergy immunotherapies industry?
• What are the key driving factors and challenges in the global allergy immunotherapies industry?
• What is the structure of the global allergy immunotherapies industry and who are the key players?
• What is the degree of competition in the global allergy immunotherapies industry?
• What are the profit margins in the global allergy immunotherapies industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Allergy Immunotherapies Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Breakup by Treatment Type

5.5 Market Breakup by Allergy Type

5.6 Market Breakup by Distribution Channel

5.7 Market Breakup by Region

5.8 Market Forecast

6 Market Breakup by Treatment Type

6.1 Subcutaneous Immunotherapy (SCIT)

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Sublingual Immunotherapy (SLIT)

6.2.1 Market Trends

6.2.2 Market Forecast

7 Market Breakup by Allergy Type

7.1 Allergic Rhinitis

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Asthma

7.2.1 Market Trends

7.2.2 Market Forecast

7.3 Food Allergy

7.3.1 Market Trends

7.3.2 Market Forecast

7.4 Venom Allergy

7.4.1 Market Trends

7.4.2 Market Forecast

7.5 Others

7.5.1 Market Trends

7.5.2 Market Forecast

8 Market Breakup by Distribution Channel

8.1 Hospital Pharmacy

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 Retail Pharmacy

8.2.1 Market Trends

8.2.2 Market Forecast

8.3 Online Pharmacy

8.3.1 Market Trends

8.3.2 Market Forecast

9 Market Breakup by Region

9.1 Europe

9.1.1 Market Trends

9.1.2 Market Forecast

9.2 North America

9.2.1 Market Trends

9.2.2 Market Forecast

9.3 Asia Pacific

9.3.1 Market Trends

9.3.2 Market Forecast

9.4 Middle East and Africa

9.4.1 Market Trends

9.4.2 Market Forecast

9.5 Latin America

9.5.1 Market Trends

9.5.2 Market Forecast

10 SWOT Analysis

10.1 Overview

10.2 Strengths

10.3 Weaknesses

10.4 Opportunities

10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview

12.2 Bargaining Power of Buyers

12.3 Bargaining Power of Suppliers

12.4 Degree of Competition

12.5 Threat of New Entrants

12.6 Threat of Substitutes

13 Price Analysis

13.1 Price Indicators

13.2 Price Structure

13.3 Margin Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/338vc9